Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells

Biomedicine and Pharmacotherapy

Volumn 66, Issue 6, 2012, Pages 454-458

  Lin, Zu Yau ^a,b   Chuang, Wan Long ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Gene expression; Hepatocellular carcinoma; Invasion; Microarray; Migration

Indexed keywords

CD163 ANTIGEN; CD70 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; EOTAXIN 3; GELATINASE A; GELATINASE B; INTERLEUKIN 18; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEONECTIN; PROTEIN CDC42; RGS4 PROTEIN; STROMELYSIN; STROMELYSIN 2;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

BIOPSY, FINE-NEEDLE; CALCIUM-BINDING PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIVER NEOPLASMS; MICROFILAMENT PROTEINS; MYOGENIC REGULATORY FACTORS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TISSUE PLASMINOGEN ACTIVATOR; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84866142615     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.04.001     Document Type: Article

References (44)

1. Lin Z.Y., Chuang W.L., Chuang Y.H., Yu M.L., Hsieh M.Y., Wang L.Y., et al. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique. J Gastroenterol Hepatol 2006, 21:398-405.
2. Lin Z.Y., Chuang W.L., Chuang Y.H. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines. Eur J Clin Invest 2009, 39:239-245.
3. Lin Z.Y., Chuang W.L. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed Pharmacother 2010, 64:348-351.
4. Lin Z.Y., Chuang W.L. Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed Pharmacother 2010, 64:659-662.
5. Yamamura H., Hirano N., Koyama H., Nishizawa Y., Takahashi K. Loss of smooth muscle calponin results in impaired blood vessel maturation in the tumor-host microenvironment. Cancer Sci 2007, 98:757-763.
6. Roda O., Ortiz-Zapater E., Martínez-Bosch N., Gutiérrez-Gallego R., Vila-Perelló M., Ampurdanés C., et al. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer. Gastroenterology 2009, 136:1379-1390.
7. Sharma M., Ownbey R.T., Sharma M.C. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 2010, 88:278-286.
8. Lau C.P., Poon R.T., Cheung S.T., Yu W.C., Fan S.T. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol 2006, 210:459-468.
9. Yin J., Chen G., Liu Y., Liu S., Wang P., Wan Y., et al. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res 2010, 29:59.
10. Thomas S.L., Alam R., Lemke N., Schultz L.R., Gutiérrez J.A., Rempel S.A. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling. Neuro Oncol 2010, 12:941-955.
11. Atorrasagasti C., Malvicini M., Aquino J.B., Alaniz L., Garcia M., Bolontrade M., et al. Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells. Int J Cancer 2010, 126:2726-2740.
12. Pan W., Jia Y., Huang T., Wang J., Tao D., Gan X., et al. Beta-catenin relieves I-mfa-mediated suppression of LEF-1 in mammalian cells. J Cell Sci 2006, 119:4850-4856.
13. Kusano S., Shiimura Y., Eizuru Y. I-mfa domain proteins specifically interact with SERTA domain proteins and repress their transactivating functions. Biochimie 2011, 93:1555-1564.
14. Tsubooka N., Ichisaka T., Okita K., Takahashi K., Nakagawa M., Yamanaka S. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells 2009, 14:683-694.
15. Chan D.W., Chan C.Y., Yam J.W., Ching Y.P., Ng I.O. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology 2006, 131:1218-1227.
16. Li C., Chen H., Hu L., Xing Y., Sasaki T., Villosis M.F., et al. Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. BMC Mol Biol 2008, 9:11.
17. Luanpitpong S., Talbott S.J., Rojanasakul Y., Nimmannit U., Pongrakhananon V., Wang L., et al. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 2010, 285:38832-38840.
18. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Fujimura L., Yoshino H., et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol 2011, 38:209-217.
19. Zhao X., Liu Y., Ma Q., Wang X., Jin H., Mehrpour M., et al. Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells. Biochem Biophys Res Commun 2009, 378:21-26.
20. Hirsch D.S., Pirone D.M., Burbelo P.D. A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes. J Biol Chem 2001, 276:875-883.
21. Takabayashi T., Xie M.J., Takeuchi S., Kawasaki M., Yagi H., Okamoto M., et al. LL5beta directs the translocation of filamin A and SHIP2 to sites of phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) accumulation, and PtdIns(3,4,5)P3 localization is mutually modified by co-recruited SHIP2. J Biol Chem 2010, 285:16155-16165.
22. Lee I., Yeom S.Y., Lee S.J., Kang W.K., Park C. A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment. Cancer Res 2010, 70:4357-4365.
23. Burnicka-Turek O., Kata A., Buyandelger B., Ebermann L., Kramann N., Burfeind P., et al. Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton. BMC Cell Biol 2010, 11:28.
24. Edgell C.J., BaSalamah M.A., Marr H.S. Testican-1: a differentially expressed proteoglycan with protease inhibiting activities. Int Rev Cytol 2004, 236:101-122.
25. Zhao W., Han H.B., Zhang Z.Q. Suppression of lung cancer cell invasion and metastasis by connexin43 involves the secretion of follistatin-like 1 mediated via histone acetylation. Int J Biochem Cell Biol 2011, 43:1459-1468.
26. Lu Q. δ-Catenin dysregulation in cancer: interactions with E-cadherin and beyond. J Pathol 2010, 222:119-123.
27. Lockwood D.S., Yeadon T.M., Clouston A.D., Crawford D.G., Fawcett J., Callaghan S.A., et al. Tumor progression in hepatocellular carcinoma: relationship with tumor stroma and parenchymal disease. J Gastroenterol Hepatol 2003, 18:666-672.
28. Ji J., Zhao L., Budhu A., Forgues M., Jia H.L., Qin L.X., et al. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010, 52:690-697.
29. Nagaharu K., Zhang X., Yoshida T., Katoh D., Hanamura N., Kozuka Y., et al. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol 2011, 178:754-763.
30. Okamura Y., Nomoto S., Kanda M., Hayashi M., Nishikawa Y., Fujii T., et al. Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma. Ann Surg Oncol 2011, 18:572-579.
31. Herman J.G., Stadelman H.L., Roselli C.E. Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity. Int J Oncol 2009, 34:1319-1327.
32. Ohta M., Kitadai Y., Tanaka S., Yoshihara M., Yasui W., Mukaida N., et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003, 22:773-778.
33. Liu Y., Li P.K., Li C., Lin J. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells. J Biol Chem 2010, 285:27429-27439.
34. Fan Y., Ye J., Shen F., Zhu Y., Yeghiazarians Y., Zhu W., et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 2008, 28:90-98.
35. Kim M.Y., Oskarsson T., Acharyya S., Nguyen D.X., Zhang X.H., Norton L., et al. Tumor self-seeding by circulating cancer cells. Cell 2009, 139:1315-1326.
36. Jung D.W., Che Z.M., Kim J., Kim K., Kim K.Y., Williams D., et al. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer 2010, 127:332-344.
37. Carbone A., Vizio B., Novarino A., Mauri F.A., Geuna M., Robino C., et al. IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival. J Immunother 2009, 32:920-931.
38. Diegmann J., Junker K., Loncarevic I.F., Michel S., Schimmel B., von Eggeling F. Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes. Neoplasia 2006, 8:933-938.
39. Zhang B., Dietrich U.M., Geng J.G., Bicknell R., Esko J.D., Wang L. Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood 2009, 114:4300-4309.
40. Yin J., Liu B., Li B., Liu Z., Xie X., Lv Z., et al. The cyclooxygenase-2 inhibitor celecoxib attenuates hepatocellular carcinoma growth and c-Met expression in an orthotopic mouse model. Oncol Res 2011, 19:131-139.
41. Li Y., Ye X., Tan C., Hongo J.A., Zha J., Liu J., et al. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene 2009, 28:3442-3455.
42. Zou H., Hu L., Li J., Zhan S., Cao K. Cloning and characterization of a novel small monomeric GTPase, RasL10B, with tumor suppressor potential. Biotechnol Lett 2006, 28:1901-1908.
43. Kim J.K., Kim P.J., Jung K.H., Noh J.H., Eun J.W., Bae H.J., et al. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression. Oncol Rep 2010, 24:607-612.
44. Xie Y., Wolff D.W., Wei T., Wang B., Deng C., Kirui J.K., et al. Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res 2009, 69:5743-5751.